Biomarker testing in non-small cell lung cancer in routine care: analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315). 17. Dezember 2020 Griesinger, F., Eberhardt, W., Nusch, A., Reiser, M., Zahn, M.-O., Maintz, C., Bernhardt, C., Losem, C., Stenzinger, A., Heukamp, L.C., Büttner, R., Marschner, N., Jänicke, M., Fleitz, A., Spring, L., Sahlmann, J., Karatas, A., Hipper, A., Weichert, W., Heilmann, M., Sadjadian, P., Gleiber, W., Grah, C., Waller, C.F., Reck, M., Rittmeyer, A., Christopoulos, P., Sebastian, M., Thomas, M., the CRISP Registry Group, 2020. Lung Cancer. https://doi.org/10.1016/j.lungcan.2020.10.012 Abstract Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression. Welt, A., Wiesweg, M., Theurer, S., Abenhardt, W., Groschek, M., Müller, L., Schröder, J., Tewes, M., Chiabudini, M., Potthoff, K., Bankfalvi, A., Marschner, N., Schuler,… Weiterlesen Application study of the EQ-5D-5L in oncology: linking self-reported quality of life of patients with advanced or metastatic colorectal cancer to clinical data from a German tumor registry. Borchert, K; Jacob, C; Wetzel, N; Jänicke, M; Eggers, E; Sauer, A; Marschner, N; Altevers, J; Mittendorf, T; Greiner, W, 2020. Health Econ Rev… Weiterlesen